Prof Nathan Lawrentschuk
Clinical (Professor)
Department of Surgery
1140 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Robotic-assisted radical prostatectomy in patients 80 years: a multi-centre experience
DOI: 10.1007/s11701-025-02945-72026
Journal article
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer
DOI: 10.1111/bju.702832026
Journal article
Effect of the November 2023 Medicare Benefits Schedule PSA Testing Reform on National Utilisation, Diagnostic Activity, and Health-System Expenditure in Australia
DOI: 10.3390/siuj70400582026
Journal article
Guideline of guidelines: pelvic lymph node dissection at time of radical prostatectomy
DOI: 10.1111/bju.702772020
Research contracts (non-grants)
Integrated Pathological, Imaging and Genomic Characterisation of Localised Prostate Cancer.
2019
Research Grant
Up-Front Psma Alliance: Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Startegies for Psma-Negative Disease
2015
Journal article
Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort
DOI: 10.1111/bju.12792
RECENT SCHOLARLY WORKS
2026
Journal article
Emerging radiotracers in prostate cancer: opportunities and challenges
DOI: 10.1111/bju.701322026
Journal article
Long-term trends in androgen-directed therapy in advanced prostate cancer: a 29-year national analysis
DOI: 10.1007/s11255-026-05003-92026
Journal article
The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection
DOI: 10.1111/bju.701882026
Journal article
End of the TRUS era: transperineal biopsy takes the lead in prostate cancer detection
DOI: 10.1038/s41585-025-01090-y2026
Journal article
Subcutaneous local anaesthetic after transperineal prostate biopsy under general anaesthesia: a randomised trial
DOI: 10.1111/bju.701352026
Journal article
Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial
DOI: 10.1016/S1470-2045(26)00120-8
RECENT PROJECTS
2019
Research Grant
Up-Front Psma Alliance: Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Strategies for Psma-Negative Disease
2019
Internal Research Grant
Up-Front Psma Alliance: Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Startegies for Psma-Negative Disease